Lilly and NextCure Announce Collaboration to Discover and Develop Novel Immuno-Oncology Medicines Read more
Gilead and Tango Announce Strategic Collaboration to Develop Next-Generation Targeted Immuno-Oncology Therapies Read more
Novo Nordisk expands its biopharm business with the acquisition of the US and Canadian rights to Macrilen (TM) Read more